Anaphylaxis found to affect 0.025% of COVID-19 mRNA vaccine recipients New research utilising real-world data suggests the rate is largely comparable to most antibiotics.
Pfizer vaccine update While it’s not anticipated the Pfizer vaccine will be rolled out in general practice, it’s important GPs understand delayed reactions and other side effects.
‘A marvel of science’: This doctor gave the COVID shot to the PM – and then to a GP What does it feel like to give someone a coronavirus vaccine? Dr Jesse Li can tell you.
Four things about mRNA vaccines researchers still want to find out At the top of the list is discovering a way to make them more stable at higher temperatures.
Pfizer/BioNTech COVID vaccine approved for use in older Australians The TGA has said there is ‘no specific risk’ associated with vaccinating older people, following reports of deaths in Norway.
Pfizer COVID vaccine first to be approved in Australia The TGA has granted provisional approval ahead of next month’s planned rollout, which will now start in late February due to production delays.
From the UK COVID frontline: what GPs can expect from the vaccine rollout GP Dr Colin Fitzpatrick talks to newsGP about coordinating the delivery of Pfizer/BioNTech vaccines across 110 Northern Ireland aged care facilities, and why they may not be suited to a nationwide rollout.
COVID vaccine restrictions possible following elderly deaths in Norway But experts have called for calm, as the connection between the Pfizer/BioNtech vaccine and mortality in frail older people remains unclear.
How important are COVID vaccine efficacy rates? Experts weigh in on whether greater investment in candidates with a higher efficacy rate would actually provide greater promise of elimination.